Solid Biosciences Inc. Common Stock (SLDB) is a publicly traded Healthcare sector company. As of September 16, 2026, SLDB trades at $8.81 with a market cap of $937.15M and a P/E ratio of -4.24. SLDB moved +5.26% today. Year to date, SLDB is +48.40%; over the trailing twelve months it is +52.46%. Its 52-week range spans $2.41 to $11.45. Analyst consensus is strong buy with an average price target of $19.17. Rallies surfaces SLDB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SLDB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SLDB recently traded at $8.81. Market cap is $937.15M. P/E ratio is -4.24. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $8.81 |
| Market Cap | $937.15M |
| P/E Ratio | -4.24 |
| EPS | $-1.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.45 |
| 52-Week Low | $2.41 |
| Volume | 11.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-174.32M |
| Gross Margin | 0.00% |
7 analysts cover SLDB: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.17.